Integra LifeSciences IART Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$4.62M-171% | -$1.7M+68.5% | -$5.4M+98.9% | -$484.07M-1,814% | -$25.29M— | ||
| $38.43M0.0% | $38.43M-0.2% | $38.52M+2.2% | $37.69M+1.4% | $37.19M-1.1% | ||
| $5.17M-11.5% | $5.84M+4.6% | $5.58M+5.4% | $5.3M+183% | $1.87M-73.9% | ||
| $1.33M+112% | -$10.95M-26.5% | -$8.65M+80.7% | -$44.83M-2,347% | -$1.83M+73.8% | ||
| -$90K— | —— | —— | —— | -$495K-137% | ||
| -$13.65M-183% | $16.45M+173% | -$22.51M-180% | $27.99M+230% | -$21.45M— | ||
| $4.33M+29.6% | $3.34M-85.7% | $23.35M+266% | $6.38M-53.4% | $13.7M+2,303% | ||
| -$19.19M-183% | $23.02M+298% | $5.78M-63.7% | $15.92M+188% | -$18M-236% | ||
| $21.88M— | —— | —— | $3.67M-79.1% | $17.55M— | ||
| $369K+102% | -$21.46M-1,319% | $1.76M+52.2% | $1.16M-16.7% | $1.39M+197% | ||
| -$630K-192% | $685K+84.6% | $371K-82.3% | $2.1M+761% | $244K-85.8% | ||
| -$1.29M+80.7% | -$6.69M+53.7% | -$14.44M-35,122% | -$41K+74.7% | -$162K+97.0% | ||
| $9.8M-17.0% | $11.82M-71.1% | $40.91M+359% | $8.92M+179% | -$11.26M-122% | ||
| $14.85M-13.7% | $17.21M+13.6% | $15.16M-24.8% | $20.15M-30.3% | $28.92M-2.3% | ||
| $0— | —— | —— | $1.5M-78.5% | $7M— | ||
| -$14.85M+57.5% | -$34.91M-124% | -$15.59M+28.0% | -$21.65M+39.7% | -$35.92M-745% | ||
| $1.38M+904% | $137K-31.2% | $199K-11.6% | $225K-89.5% | $2.14M+1,471% | ||
| $0— | —— | —— | $13.85M+433% | $2.6M— | ||
| $8.3M-65.9% | $24.34M— | —— | —— | $35.38M— | ||
| -$1.49M-193% | $1.61M— | $0-100% | $12.68M+180% | $4.53M+156% | ||
| $1.76M— | —— | —— | -$21.19M-191% | -$7.27M— | ||
| $995K-2.0% | $1.02M-22.8% | $1.32M-30.4% | $1.89M+36.5% | $1.39M-1.1% | ||
| -$1.29M+80.7% | -$6.69M+53.7% | -$14.44M-35,122% | -$41K+74.7% | -$162K+97.0% | ||
| $369K+102% | -$21.46M-1,319% | $1.76M+52.2% | $1.16M-16.7% | $1.39M+197% | ||
| -$1.39M-17,213% | -$8K+99.2% | -$1M-21.5% | -$824K+45.4% | -$1.51M-238% | ||
| $21.88M— | —— | —— | $3.67M-79.1% | $17.55M— | ||
| —— | $324.75K0.0% | $324.75K0.0% | $324.75K0.0% | $324.75K-84.6% | ||
| $330K— | —— | —— | —— | -$254K— | ||
| $38.43M0.0% | $38.43M-0.2% | $38.52M+2.2% | $37.69M+1.4% | $37.19M-1.1% | ||
| $760K— | —— | —— | —— | $957K— | ||
| $35.59M+41.9% | $25.09M-35.2% | $38.69M+144% | $15.89M+4.2% | $15.24M-61.8% | ||
| -$630K-192% | $685K+84.6% | $371K-82.3% | $2.1M+761% | $244K-85.8% | ||
| $0— | —— | —— | $13.85M+433% | $2.6M— | ||
| $44.5M-10.5% | $49.7M-91.8% | $603.7M+4,580% | $12.9M-76.3% | $54.4M+53.7% | ||
| -$5.05M+6.5% | -$5.4M— | —— | -$11.23M+72.1% | -$40.18M-290% | ||
| -$5.05M+6.5% | -$5.4M— | —— | -$11.23M+72.1% | -$40.18M-290% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Integra LifeSciences generate?
- Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
- What is Integra LifeSciences's free cash flow?
- After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
- Where does Integra LifeSciences's cash flow data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
